December 07, 2016 10:34 AM ET

Pharmaceuticals

Company Overview of Aclaris Therapeutics, Inc.

Executive Profile

Christopher V. Powala

Co-Founder and Chief Operating Officer, Aclaris Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 Board Members in 0 different organizations across 3 different industries.

57$2,433,328
As of Fiscal Year 2015

Background

Mr. Christopher V. Powala co-founded Aclaris Therapeutics, Inc. in July 2012 and has been its Chief Operating Officer since July 2012. Mr. Powala co-founded Vicept Therapeutics, Inc. in 2009 and served as its Chief Operating Officer. He served as Vice President of Regulatory Affairs & Clinical Operations of Vital Therapies, Inc. He has over 23 years of experience in the pharmaceutical industry and over 20 years in regulatory affairs and drug development. Prior to Vital ...

Corporate Headquarters

101 Lindenwood Drive
Malvern, Pennsylvania 19355

United States

Phone: 484-324-7933
Fax: --

Board Members Memberships

There is no Board Members Memberships data available.

Education

Bachelor's Degree
Regents College, London

Other Affiliations

Annual Compensation

Salary$305,271
Total Annual Compensation$305,271

Stocks Options

Restricted Stock Awards$186,420
All Other Compensation$11,948
Exercisable Options$14,638
Exercisable Options Value$375,906
Unexercisable Options$167,251
Unexercisable Options Value$2,135,188
Total Value of Options$2,511,093
Total Number of Options$181,889

Total Compensation

Total Annual Cash Compensation$408,800
Total Short Term Compensation$305,271
Other Long Term Compensation$198,368
Total Calculated Compensation$2,433,328
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Aclaris Therapeutics, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.